Tivic Health™ to Demonstrate ClearUP™ Sinus Pain Relief Device At CES 2019
SAN FRANCISCO--(BUSINESS WIRE)--Dec 17, 2018--Tivic Health, a bioelectronic device company, will demonstrate ClearUP™ Sinus Pain Relief – the first bioelectronic treatment for sinus pain at CES 2019. ClearUP offers a new way to manage sinus pain for the 27 million Americans who suffer chronic sinusitis and the 17 million who suffer allergic rhinitis (hay fever).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181217005564/en/
ClearUP Sinus Pain Relief treatment for sinus pain (Photo: Business Wire)
Tivic Health will exhibit at CES Eureka Park, Sands Expo, booth 53355 and CES Unveiled, January 6.
ClearUP Sinus Pain Relief is not a pill, spray or flush - it’s a small, handheld device used exclusively on the outside of the sinus passages. As the user glides ClearUP along their cheek, nose and brow bone, it locates areas of skin where tiny electrical waveforms can pass easily. This low-current electrical stimulation, called microcurrent, stimulates the nerves under the skin to relieve sinus pain.
“ClearUP is a groundbreaking product for sinus pain that was successfully tested in a double-blind Randomized Control Trial at Stanford Sinus Center. After just one treatment, three out of four users achieved sinus pain relief,” said Jennifer Ernst, CEO, Tivic Health. “ClearUP is taking the power of bioelectronic technology and providing consumers with a simple, non-invasive option to relieve sinus pain.”
ClearUP Sinus Pain Relief is an investigational technology. Claims have not been evaluated by the FDA. ClearUP is not currently for sale in the U.S. FDA 510 clearance is pending.
ClearUP FactsEasy one-button control Three intensity levels for user customization Light and vibration system helps users target treatment points Quick five-minute treatment Portable for home, work, travel Non-invasive, no chemicals or side effects Rechargeable & reusable Price: $149
Tivic Health plans to sell ClearUP Sinus Pain Relief, upon FDA clearance, at www.tivichealth.com and more.
About Bioelectronics In September 2018, the World Economic Forum named bioelectronics or “electroceuticals” as one of the top 10 disruptive technologies poised to change medical treatment. A $6.2 billion industry, bioelectronic medicine is the convergence of biology and electrical engineering. Devices work by modulating the electrical activity in peripheral and central nerves in order to mitigate both symptoms and underlying causes of diseases.
About Tivic Health Systems Inc. Tivic Health is a bioelectronic device company dedicated to developing microcurrent therapy solutions for chronic diseases and conditions. The company is harnessing the power of bioelectronic medicine and neuromodulation into home-use products that empower people to improve their health and quality of life. www.tivichealth.com
Forward Looking Statement This news release contains forward-looking statements that are based on the current expectations and beliefs of Tivic Health Systems Inc. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including FDA clearance, product launch and timing.
View source version on businesswire.com:https://www.businesswire.com/news/home/20181217005564/en/
CONTACT: Cheryl Delgreco
KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA
INDUSTRY KEYWORD: TECHNOLOGY CONSUMER ELECTRONICS HEALTH BIOTECHNOLOGY MEDICAL DEVICES OTHER HEALTH MEDICAL SUPPLIES GENERAL HEALTH
SOURCE: Tivic Health
Copyright Business Wire 2018.
PUB: 12/17/2018 11:40 AM/DISC: 12/17/2018 11:41 AM